Studies have also shown that statin medications lower inflammation, as measured by high sensitivity C Reactive Protein. After the JUPITER trial was published, many healthcare professionals beleived that this is possibly the mechanism by which statin medications such as lipitor, zocor, pravachol and crestor decrease risk of death and exert their health benefits.
——————
By Rob Waters
April 29 (Bloomberg) — Patients who reduced their cholesterol and blood pressure by taking Pfizer Inc.’s Lipitor after suffering a stroke were less likely to have a second attack, researchers reported today.
People who lowered their blood pressure, cholesterol and blood fats called triglycerides to recommended levels with the drug cut their risk of a second stroke by 65 percent, according to the study funded by New York-based Pfizer. They also cut their risk of heart attack and other cardiovascular damage by 75 percent. Researchers presented results today at a meeting of the American Academy of Neurology in Seattle.
All cholesterol-lowering drugs knows as statins are likely to have a similar effect, said Samuel Hunter, a neurologist at the Advanced Neurosciences Institute in Franklin, Tennessee, in an interview yesterday in Seattle. Stroke is the third leading cause of death in the country and causes more serious long-term disabilities than any other disease, according to the National Institutes of Health.
“It is a message of hope for patients,” said Pierre Amarenco, a researcher at Denis Diderot University in Paris and the lead author of the study. “We can now tell them that if they are adherent to treatment, they may reduce the risk” of strokes and of major cardiovascular events...read more here…
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.